Both in Biotechnology
IRulya Therapeutics vs Tevogen
| Metric | IRLA | TVGN |
|---|---|---|
| Price | $31.00 | $5.59 |
| Market cap | $336.1M | $93.7M |
| Today | +5.77% | +0.54% |
| 1 month | — | −20.8% |
| 6 months | — | −25.3% |
| Year to date | — | −66.2% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 60.3% |
| Short % of float | 17.2% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).